Skip to main content

Advertisement

SpringerLink
Log in

Effect of teriparatide on pregnancy and lactation-associated osteoporosis with multiple vertebral fractures

  • Case Report
  • Published:
Journal of Bone and Mineral Metabolism Aims and scope Submit manuscript

Abstract

Pregnancy and lactation-associated osteoporosis (PLO) is very rare, but it can cause severe vertebral compression fractures with disabling back pain. PLO patients have commonly been treated with antiresorptive agents against high bone turnover. There are, however, some concerns regarding the use of bisphosphonates: (1) PLO occurs during the first pregnancy with a high possibility of recurrence during the second pregnancy, (2) long-term outcomes of bisphosphonates in PLO are lacking, and (3) there is a possibility of bisphosphonates accumulated in the bones crossing the placenta. Therefore, alternative therapies must be considered. We analyzed the effect of teriparatide (TPTD), the human recombinant parathyroid hormone (1–34), for 18 months in three women with PLO. Multiple vertebral fractures with severe back pain appeared within 6 months after their first childbirth. Two of them had a family history of osteoporosis. Lactation was discontinued immediately after diagnosis of PLO. Calcium carbonate, cholecalciferol, and TPTD were prescribed. The back pain immediately resolved. Bone mineral density (BMD) increased by 14.5–25.0% (mean 19.5%) at the lumbar spine and by 9.5–16.7% (mean 13.1%) at the femoral neck, after 18 months of treatment. The final Z scores in these PLO patients were nearly normalized. Two women had a second baby without any complication. BMD significantly improved after 18 months of treatment with TPTD without further fractures. In conclusion, TPTD should be considered to avoid long-term morbidity in young patients with PLO and is highly encouraged for use in PLO patients with multiple vertebral fractures.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Nordin BE, Roper A (1955) Post-pregnancy osteoporosis; a syndrome? Lancet 268:431–434

    Article  PubMed  CAS  Google Scholar 

  2. Jackson WP (1958) Osteoporosis of unknown cause in younger people: idiopathic osteoporosis. J Bone Joint Surg Br 40-B:420–441

    PubMed  CAS  Google Scholar 

  3. Gruber HE, Gutteridge DH, Baylink DJ (1984) Osteoporosis associated with pregnancy and lactation: bone biopsy and skeletal features in three patients. Metab Bone Dis Relat Res 5:159–165

    Article  PubMed  CAS  Google Scholar 

  4. Smith R, Stevenson JC, Winearls CG, Woods CG, Wordsworth BP (1985) Osteoporosis of pregnancy. Lancet 1:1178–1180

    Article  PubMed  CAS  Google Scholar 

  5. Dunne F, Walters B, Marshall T, Heath DA (1993) Pregnancy associated osteoporosis. Clin Endocrinol (Oxf) 39:487–490

    Article  CAS  Google Scholar 

  6. Yamamoto N, Takahashi HE, Tanizawa T, Kawashima T, Endo N (1994) Bone mineral density and bone histomorphometric assessments of postpregnancy osteoporosis: a report of five patients. Calcif Tissue Int 54:20–25

    Article  PubMed  CAS  Google Scholar 

  7. Smith R, Phillips AJ (1998) Osteoporosis during pregnancy and its management. Scand J Rheumatol Suppl 107:66–67

    PubMed  CAS  Google Scholar 

  8. Carbone LD, Palmieri GM, Graves SC, Smull K (1995) Osteoporosis of pregnancy: long-term follow-up of patients and their offspring. Obstet Gynecol 86:664–666

    Article  PubMed  CAS  Google Scholar 

  9. Di Gregorio S, Danilowicz K, Rubin Z, Mautalen C (2000) Osteoporosis with vertebral fractures associated with pregnancy and lactation. Nutrition 16:1052–1055

    Article  PubMed  CAS  Google Scholar 

  10. Phillips AJ, Ostlere SJ, Smith R (2000) Pregnancy-associated osteoporosis: does the skeleton recover? Osteoporos Int 11:449–454

    Article  PubMed  CAS  Google Scholar 

  11. O’Sullivan SM, Grey AB, Singh R, Reid IR (2006) Bisphosphonates in pregnancy and lactation-associated osteoporosis. Osteoporos Int 17:1008–1012

    Article  PubMed  Google Scholar 

  12. Stumpf UC, Kurth AA, Windolf J, Fassbender WJ (2007) Pregnancy-associated osteoporosis: an underestimated and underdiagnosed severe disease. A review of two cases in short- and long-term follow-up. Adv Med Sci 52:94–97

    PubMed  CAS  Google Scholar 

  13. Tanriover MD, Oz SG, Sozen T, Kilicarslan A, Guven GS (2009) Pregnancy- and lactation-associated osteoporosis with severe vertebral deformities: can strontium ranelate be a new alternative for the treatment? Spine J 9:e20–e24

    Article  PubMed  Google Scholar 

  14. Hellmeyer L, Boekhoff J, Hadji P (2010) Treatment with teriparatide in a patient with pregnancy-associated osteoporosis. Gynecol Endocrinol 26:725–728

    Article  PubMed  CAS  Google Scholar 

  15. Seo JY, Kim HK, Choi CS, Kim DM, Ihm SH, Yoo JM, Choi MG, Yoo HJ, Park SW, Lee JY (2001) A case of postpregnancy spinal osteoporosis. J Korean Soc Endocrinol 16(2):265–270

    Google Scholar 

  16. Lee J-E, Jang J-S, Ko S-H, Kim M-H, Lim D-J, Kang M-I, Cha B-Y, Hong S-H, Bae J-S, Ryu K-S (2011) Pregnancy-induced osteoporosis combined with multiple compression fractures: a case report. Endocrinol Metab 26:150–154

    Article  Google Scholar 

  17. Sowers MF, Hollis BW, Shapiro B, Randolph J, Janney CA, Zhang D, Schork A, Crutchfield M, Stanczyk F, Russell-Aulet M (1996) Elevated parathyroid hormone-related peptide associated with lactation and bone density loss. JAMA 276:549–554

    Article  PubMed  CAS  Google Scholar 

  18. Khovidhunkit W, Epstein S (1996) Osteoporosis in pregnancy. Osteoporos Int 6:345–354

    Article  PubMed  CAS  Google Scholar 

  19. Patlas N, Golomb G, Yaffe P, Pinto T, Breuer E, Ornoy A (1999) Transplacental effects of bisphosphonates on fetal skeletal ossification and mineralization in rats. Teratology 60:68–73

    Article  PubMed  CAS  Google Scholar 

  20. Hassen-Zrour S, Korbaa W, Bejia I, Saidani Z, Bergaoui N (2010) Maternal and fetal outcome after long-term bisphosphonate exposure before conception. Osteoporos Int 21:709–710

    Article  PubMed  CAS  Google Scholar 

  21. Losada I, Sartori L, Di Gianantonio E, Zen M, Clementi M, Doria A (2010) Bisphosphonates in patients with autoimmune rheumatic diseases: can they be used in women of childbearing age? Autoimmun Rev 9:547–552

    Article  PubMed  CAS  Google Scholar 

  22. Kalkwarf HJ, Specker BL (2002) Bone mineral changes during pregnancy and lactation. Endocrine 17:49–53

    Article  PubMed  CAS  Google Scholar 

  23. Glerean M, Plantalech L (2000) Osteoporosis in pregnancy and lactation. Medicina (B Aires) 60:973–981

    CAS  Google Scholar 

  24. Laskey MA, Prentice A, Hanratty LA, Jarjou LM, Dibba B, Beavan SR, Cole TJ (1998) Bone changes after 3 mo of lactation: influence of calcium intake, breast-milk output, and vitamin D-receptor genotype. Am J Clin Nutr 67:685–692

    PubMed  CAS  Google Scholar 

  25. McNicholl DM, Heaney LG (2010) The safety of bisphosphonate use in pre-menopausal women on corticosteroids. Curr Drug Saf 5:182–187

    Article  PubMed  CAS  Google Scholar 

  26. Nolen GA, Buehler EV (1971) The effects of disodium etidronate on the reproductive functions and embryogeny of albino rats and New Zealand rabbits. Toxicol Appl Pharmacol 18:548–561

    Article  PubMed  CAS  Google Scholar 

  27. Russell RG, Watts NB, Ebetino FH, Rogers MJ (2008) Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy. Osteoporos Int 19:733–759

    Article  PubMed  CAS  Google Scholar 

  28. Quattrocchi E, Kourlas H (2004) Teriparatide: a review. Clin Ther 26:841–854

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest

All authors have no conflicts of interest.

Author information

Authors and Affiliations

  1. Department of Internal Medicine, College of Medicine, Yonsei University, 50 Yonsei-ro, Seodaemun-gu, Seoul, 120-752, Korea

    Eun Yeong Choe, Je Eun Song, Kyeong Hye Park, Hannah Seok, Eun Jig Lee, Sung-Kil Lim & Yumie Rhee

  2. Endocrine Research Institute, Seoul, Korea

    Eun Jig Lee, Sung-Kil Lim & Yumie Rhee

Authors
  1. Eun Yeong Choe
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Je Eun Song
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kyeong Hye Park
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hannah Seok
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Eun Jig Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Sung-Kil Lim
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Yumie Rhee
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yumie Rhee.

About this article

Cite this article

Choe, E.Y., Song, J.E., Park, K.H. et al. Effect of teriparatide on pregnancy and lactation-associated osteoporosis with multiple vertebral fractures. J Bone Miner Metab 30, 596–601 (2012). https://doi.org/10.1007/s00774-011-0334-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00774-011-0334-0

Keywords

Search

Navigation